21-42388417-T-C

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001256317.3(TMPRSS3):​c.432A>G​(p.Gln144Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00388 in 1,614,210 control chromosomes in the GnomAD database, including 195 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 109 hom., cov: 33)
Exomes 𝑓: 0.0022 ( 86 hom. )

Consequence

TMPRSS3
NM_001256317.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.31
Variant links:
Genes affected
TMPRSS3 (HGNC:11877): (transmembrane serine protease 3) This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a serine protease domain, a transmembrane domain, an LDL receptor-like domain, and a scavenger receptor cysteine-rich domain. Serine proteases are known to be involved in a variety of biological processes, whose malfunction often leads to human diseases and disorders. This gene was identified by its association with both congenital and childhood onset autosomal recessive deafness. This gene is expressed in fetal cochlea and many other tissues, and is thought to be involved in the development and maintenance of the inner ear or the contents of the perilymph and endolymph. This gene was also identified as a tumor-associated gene that is overexpressed in ovarian tumors. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 21-42388417-T-C is Benign according to our data. Variant chr21-42388417-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 46120.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.31 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0663 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMPRSS3NM_001256317.3 linkc.432A>G p.Gln144Gln synonymous_variant Exon 5 of 13 ENST00000644384.2 NP_001243246.1 P57727-5
TMPRSS3NM_024022.4 linkc.432A>G p.Gln144Gln synonymous_variant Exon 5 of 13 NP_076927.1 P57727-1
TMPRSS3NM_032405.2 linkc.432A>G p.Gln144Gln synonymous_variant Exon 5 of 9 NP_115781.1 P57727-3
TMPRSS3NM_032404.3 linkc.51A>G p.Gln17Gln synonymous_variant Exon 2 of 10 NP_115780.1 P57727-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMPRSS3ENST00000644384.2 linkc.432A>G p.Gln144Gln synonymous_variant Exon 5 of 13 NM_001256317.3 ENSP00000494414.1 P57727-5

Frequencies

GnomAD3 genomes
AF:
0.0198
AC:
3014
AN:
152214
Hom.:
105
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0682
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00817
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000500
Gnomad OTH
AF:
0.0139
GnomAD3 exomes
AF:
0.00519
AC:
1305
AN:
251390
Hom.:
42
AF XY:
0.00371
AC XY:
504
AN XY:
135894
show subpopulations
Gnomad AFR exome
AF:
0.0677
Gnomad AMR exome
AF:
0.00370
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000378
Gnomad OTH exome
AF:
0.00489
GnomAD4 exome
AF:
0.00221
AC:
3224
AN:
1461878
Hom.:
86
Cov.:
31
AF XY:
0.00192
AC XY:
1399
AN XY:
727240
show subpopulations
Gnomad4 AFR exome
AF:
0.0671
Gnomad4 AMR exome
AF:
0.00452
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000162
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000372
Gnomad4 OTH exome
AF:
0.00530
GnomAD4 genome
AF:
0.0199
AC:
3032
AN:
152332
Hom.:
109
Cov.:
33
AF XY:
0.0189
AC XY:
1406
AN XY:
74508
show subpopulations
Gnomad4 AFR
AF:
0.0684
Gnomad4 AMR
AF:
0.00816
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000500
Gnomad4 OTH
AF:
0.0137
Alfa
AF:
0.00870
Hom.:
23
Bravo
AF:
0.0224
Asia WGS
AF:
0.00722
AC:
25
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000415

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Dec 08, 2017
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Dec 21, 2010
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Gln144Gln in exon 5 of TMPRSS3: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue is not located near a splice junction, is listed in dbSNP (rs61731564, 3 control submissions) and ha s been found in 10% of Black and/or Hispanic cases in our laboratory. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:3
May 24, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 8 Benign:2
Feb 14, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
12
DANN
Benign
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61731564; hg19: chr21-43808526; API